Cited by 229Systemic Lupus Erythematosus ResearchBlood Coagulation and Thrombosis MechanismsHemophilia Treatment and Research

The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.

Laboratory Identification of Lupus Anticoagulants: Results of the Second International Workshop for Identification of Lupus Anticoagulants: On behalf of the Subcommittee on Lupus Anticoagulants/Antiphospholipid Antibodies of the ISTH

Brandt, John T, Barna, Linda K, Triplett, Douglas A·1995·Thrombosis and Haemostasis

DOI 10.1055/s-0038-1649988

Open this paper in CoChat — free account

Abstract

Summary: Lupus anticoagulants (LAs) are antibodies that interfere with phospholipid dependent coagulation reactions in vitro. This workshop was designed to provide the participants with an experience in identification of LAs, to evaluate different criteria for mixing studies, to assess the performance of recently introduced confirmatory studies and to assess the performance of two potential surrogate LA control plasmas. The results demonstrate that there continues to be significant variation in the sensitivity and responsiveness of APTT reagents to the presence of LAs, confirming the need for more than one screening assay before the presence of a LA can be ruled out. In this workshop, the best distinction between factor deficiency and inhibitors was obtained using a 1:1 mix of normal plasma with patient plasma and the criterion defining correction as shortening of the APTT to within 5 s of the APTT of pooled normal plasma. A 4:1 mix of patient to normal plasma did not work well in distinguishing factor deficiency from inhibitors. The platelet neutralization procedure, DVVconfirm® and StaClot LA® all gave positive results with the LA samples. False positive platelet neutralization procedures were seen with the samples from patients on oral anticoagulants and a factor V inhibitor. False positive StaClot LA results were obtained with high titer factor VIII inhibitors. Both of the potential surrogate plasmas gave variable results with multiple assays; they can not be recommended for routine use at present.

Integrity signals

Registry

Crossref · 10.1055/s-0038-1649988

Cites

28 of 28 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Antiphospholipid Antibodies: Anticardiolipin and the Lupus Anticoagulant in Systemic Lupus Erythematosus (SLE) and in Non-SLE Disorders
Love, P. E., & Santoro, S. A. (1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-112-9-682 · Cited by 1,095
Lupus Anticoagulant IgG's (LA) Are Not Directed to Phospholipids only, but to a Complex of Lipid-Bound Human Prothrombin
Bevers, E. M., Galli, M., Barbui, T., Comfurius, P., & Zwaal, R. F. A. (1991) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1646476 · Cited by 575
Thrombosis in Patients with the Lupus Anticoagulant
Mueh, J., HERBST, K. D., & RAPAPORT, S. I. (1980) · Annals of Internal Medicine · doi:10.7326/0003-4819-92-2-156 · Cited by 502
Antiphospholipid antibodies directed against a combination of phospholipids with prothrombin, protein C, or protein S: an explanation for their pathogenic mechanism? [see comments]
Oosting, J. D., Derksen, R. H. W. M., Bobbink, I. W. G., Hackeng, T. M., Bouma, B. N., & de Groot, P. G. (1993) · Blood · doi:10.1182/blood.v81.10.2618.2618 · Cited by 487
Immunology and clinical importance of antiphospholipid antibodies
McNeil, H. P., Chesterman, C. N., & Krilis, S. A. (1991) · Advances in immunology · doi:10.1016/s0065-2776(08)60777-4 · Cited by 481
The use of the dilute Russell viper venom time for the diagnosis of lupus anticoagulants
Thiagarajan, P., Pengo, V., & Shapiro, S. (1986) · Blood · doi:10.1182/blood.v68.4.869.869 · Cited by 422
The Spectrum of Neurologic Disease Associated With Antiphospholipid Antibodies
Levine, S. R. (1987) · Archives of Neurology · doi:10.1001/archneur.1987.00520200078024 · Cited by 301
INTRAUTERINE DEATH AND CIRCULATING ANTICOAGULANT (“ANTITHROMBOPLASTIN”)
Nilsson, I. M., Åstedt, B., Hedner, U. K. E., et al. (1975) · Acta Medica Scandinavica · doi:10.1111/j.0954-6820.1975.tb04897.x · Cited by 293
Laboratory Diagnosis of Lupus Inhibitors: A Comparison of the Tissue Thromboplastin Inhibition Procedure with a New Platelet Neutralization Procedure
Triplett, D. A., Brandt, J. T., Kaczor, D. A., et al. (1983) · American Journal of Clinical Pathology · doi:10.1093/ajcp/79.6.678 · Cited by 276
Self-citation
Guidelines for testing and revised criteria for lupus anticoagulants. SSC Subcommittee for the Standardization of Lupus Anticoagulants.
Exner, T., Triplett, D. A., Taberner, D. A., & Machin, S. J. (1991) · PubMed · Cited by 243
Self-citation

Show all 27 references

Sorted by citations

Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies)
Rai, R., Cohen, H., Dave, M., & Regan, L. (1997) · BMJ · doi:10.1136/bmj.314.7076.253 · Cited by 1,113
Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature
Galli, M., Luciani, D., Bertolini, G., & Barbui, T. (2003) · Blood · doi:10.1182/blood-2002-02-0441 · Cited by 972
A comparison of two intensities of warfarin for the prevention of recurrent thrombosis in patients with the antiphospholipid antibody syndrome
Crowther, M. A., Ginsberg, J. S., Julian, J., Denburg, J., Hirsh, J., Douketis, J., Laskin, C., Fortin, P., Anderson, D., Kearon, C., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa035241 · Cited by 919
Antiphospholipid Antibodies and subsequent thrombo-occlusive events in patients with ischemic stroke
(2004) · JAMA · doi:10.1001/jama.291.5.576 · Cited by 478
Management of Antiphospholipid Antibody Syndrome
Lim, W., Crowther, M. A., & Eikelboom, J. W. (2006) · JAMA · doi:10.1001/jama.295.9.1050 · Cited by 441
Endothelial microparticles: a potential contribution to the thrombotic complications of the antiphospholipid syndrome
Camoin‐Jau, L., Sabatier, F., Arnoux, D., Anfosso, F. J., Bardin, N., Veit, V., Combes, V., Gentile, S., Moal, V., Sanmarco, M., et al. (2004) · Thrombosis and Haemostasis · doi:10.1160/th03-07-0487 · Cited by 228
β2-glycoprotein I–dependent lupus anticoagulant highly correlates with thrombosis in the antiphospholipid syndrome
de Laat, H. B., Derksen, R. H. W. M., Urbanus, R. T., Roest, M., & de Groot, P. G. (2004) · Blood · doi:10.1182/blood-2004-03-1107 · Cited by 219
Practical applications of snake venom toxins in haemostasis
Marsh, N., & Williams, V. (2005) · Toxicon · doi:10.1016/j.toxicon.2005.02.016 · Cited by 217
Vasculitis in Systemic Lupus Erythematosus
Ramos‐Casals, M., Nardi, N. N., Lagrutta, M., et al. (2006) · Medicine · doi:10.1097/01.md.0000216817.35937.70 · Cited by 217
Case-control study of the frequency of thrombophilic disorders in couples with late foetal loss and no thrombotic antecedent--the Nîmes Obstetricians and Haematologists Study5 (NOHA5).
Gris, J., Quéré, I., Monpeyroux, F., Mercier, É., Ripart-Neveu, S., Tailland, M.-L., Hoffet, M., Berlan, J., Daurès, J., & Marès, P. (1999) · PubMed · Cited by 207
Management of the obstetric antiphospholipid syndrome
Derksen, R. H. W. M., Khamashta, M. A., & Branch, D. W. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20105 · Cited by 200
How we diagnose the antiphospholipid syndrome
Giannakopoulos, B., Passam, F. H., Ioannou, Y., & Krilis, S. A. (2008) · Blood · doi:10.1182/blood-2007-12-129627 · Cited by 187
Increased Risk for Heart Valve Disease Associated With Antiphospholipid Antibodies in Patients With Systemic Lupus Erythematosus
Zuily, S., Regnault, V., Selton‐Suty, C., Eschwège, V., Bruntz, J. F., Bode-Dotto, E., de Maistre, E., Dotto, P., Perret‐Guillaume, C., Lecompte, T., et al. (2011) · Circulation · doi:10.1161/circulationaha.111.028522 · Cited by 177
The potential role of heparin in assisted conception
Nelson, S. M., & Greer, I. A. (2008) · Human Reproduction Update · doi:10.1093/humupd/dmn031 · Cited by 161
Circulating platelet-derived microparticles in systemic lupus erythematosus
Alfaro, G., Manuela Goycoolea, M., Quiroga, T., Ocqueteau, M. E., Massardo, L., V, Pérez, C., Sáez, C. G., Panes, O., Matus, V., Mezzano, D., et al. (2005) · Thrombosis and Haemostasis · doi:10.1160/th05-05-0310 · Cited by 157
Preclinical vascular disease in systemic lupus erythematosus and primary antiphospholipid syndrome
Jiménez, S., García‐Criado, Á., Tàssies, D., Reverter, J. C., Cervera, R., Gilabert, M. R., Zambón, D., Ros, E., Brú, C., & Font, J. (2005) · Lara D. Veeken · doi:10.1093/rheumatology/keh581 · Cited by 144
Antiphospholipid and antiprotein syndromes in non-thrombotic, non-autoimmune women with unexplained recurrent primary early foetal loss. The Nîmes Obstetricians and Haematologists Study--NOHA.
Gris, J., Quéré, I., Sanmarco, M., Boutiere, B., Mercier, É., Amiral, J., Hubert, A., Ripart-Neveu, S., Hoffet, M., Tailland, M.-L., et al. (2000) · PubMed · Cited by 135
Antiphospholipid Syndrome: Diagnostic Aspects of Lupus Anticoagulants
Arnout, J. (2001) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1616204 · Cited by 121
Antiphospholipid syndrome and recurrent thrombosis in children
Berkun, Y., Padeh, S., Barash, J., Uziel, Y., Harel, L., Mukamel, M., Revel‐Vilk, S., & Kenet, G. (2006) · Arthritis Care & Research · doi:10.1002/art.22360 · Cited by 118
Clinical study and follow-up of 100 patients withthe antiphospholipid syndrome
Muñoz-Rodríguez, F. J., Font, J., Cervera, R., Reverter, J. C., Tàssies, D., Espinosa, G., López-Soto, A., Carmona, F., Balasch, J., Ordinas, A., et al. (1999) · Seminars in Arthritis and Rheumatism · doi:10.1016/s0049-0172(99)80029-8 · Cited by 114
Atypical Autoantibodies in Patients with Primary Sjögren Syndrome: Clinical Characteristics and Follow-Up of 82 Cases
Ramos‐Casals, M., Nardi, N. N., Brito‐Zerón, P., et al. (2006) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2005.12.004 · Cited by 114
Comparative incidence of a first thrombotic event in purely obstetric antiphospholipid syndrome with pregnancy loss: the NOH-APS observational study
Gris, J., Bouvier, S., Molinari, N., Galanaud, J. ‐., Cochery-Nouvellon, É., Mercier, É., Fabbro-Péray, P., Balducchi, J.-P., Marès, P., Quéré, I., et al. (2011) · Blood · doi:10.1182/blood-2011-09-381913 · Cited by 108
Potentially Clinically Important Inaccuracies in Testing for the Lupus Anticoagulant: an Analysis of Results from three Surveys of the UK National External Quality Assessment Scheme (NEQAS) for Blood Coagulation
Jennings, I., Kitchen, S., Woods, T. A. L., Preston, F. E., & Greaves, M. (1997) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1656080 · Cited by 103
Lupus Anticoagulant Testing in Europe: An Analysis of Results from the First European Concerted Action on Thrombophilia (ECAT) Survey Using Plasmas Spiked with Monoclonal Antibodies against Human β2-Glycoprotein I
Meijer, P., Vermylen, J., & Arnout, J. (1999) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1614601 · Cited by 96
Antiphospholipid/antiprotein antibodies, hemostasis-related autoantibodies, and plasma homocysteine as risk factors for a first early pregnancy loss: a matched case-control study
Gris, J., Perneger, T., Quéré, I., Mercier, É., Fabbro-Péray, P., Lavigne-Lissalde, G., Hoffet, M., Déchaud, H., Boyer, J.-C., Ripart-Neveu, S., et al. (2003) · Blood · doi:10.1182/blood-2003-01-0320 · Cited by 93
Laboratory diagnosis of the antiphospholipid syndrome
Wislöff, F., Jacobsen, E. M., & Liestøl, S. (2002) · Thrombosis Research · doi:10.1016/s0049-3848(02)00400-0 · Cited by 92
Prevalence of hepatitis C virus infection in patients with antiphospholipid syndrome
Muñoz, F. J., Tàssies, D., Font, J., et al. (1999) · Journal of Hepatology · doi:10.1016/s0168-8278(99)80127-5 · Cited by 86
Pulmonary embolism—experience at a single children's hospital
Rajpurkar, M., Warrier, I. A., Chitlur, M., Sabo, C. S., Frey, M. J., Hollon, W., & Lusher, J. M. (2006) · Thrombosis Research · doi:10.1016/j.thromres.2006.05.016 · Cited by 84
Influence of aspirin on the clinical outcomes of 103 anti-phospholipid antibodies-positive patients
Hereng, T., Lambert, M., HACHULLA, E., Samor, M., Dubucquoi, S., Caron, C., Launay, D., Morell‐Dubois, S., Queyrel, V., & Hatron, P. (2007) · Lupus · doi:10.1177/0961203307084724 · Cited by 84
The presence of IgG antibodies against β2‐glycoprotein I predicts the risk of thrombosis in patients with the lupus anticoagulant
Rintelen, C., Vormittag, R., Sailer, T., Lehr, S., Quehenberger, P., Rumpold, H., Male, C., & Pabinger, I. (2005) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2005.01394.x · Cited by 82
Laboratory Testing for Lupus Anticoagulants: A Review of Issues Affecting Results
Tripodi, A. (2007) · Clinical Chemistry · doi:10.1373/clinchem.2007.089524 · Cited by 81
Improvements in Factor VIII Inhibitor Detection: From Bethesda to Nijmegen
Verbruggen, B., van Heerde, W. L., & Gorkom, B. A. P. L. (2009) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-0029-1245107 · Cited by 78
Coagulation disorders in young adults with acute cerebral ischaemia
Munts, A. G., van Genderen, P. J. J., Dippel, D. W. J., van Kooten, F., & Koudstaal, P. J. (1997) · Journal of Neurology · doi:10.1007/s004150050169 · Cited by 78
Risk factors associated with the death of patients hospitalized for juvenile systemic lupus erythematosus
Facó, M. M. M., Leone, C., Campos, L. M. A., et al. (2007) · Brazilian Journal of Medical and Biological Research · doi:10.1590/s0100-879x2006005000110 · Cited by 79
Mixing tests: diagnostic aides in the investigation of prolonged prothrombin times and activated partial thromboplastin times
Orellana, D., & Kershaw, G. (2013) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-0033-1336832 · Cited by 76
Current insight into diagnostics and pathophysiology of the antiphospolipid syndrome
Urbanus, R. T., Derksen, R. H. W. M., & de Groot, P. G. (2007) · Blood Reviews · doi:10.1016/j.blre.2007.09.001 · Cited by 76
An association analysis of HLA-DRB1 with systemic lupus erythematosus and rheumatoid arthritis in a Japanese population: effects of *09:01 allele on disease phenotypes
Shimane, K., Kochi, Y., Suzuki, A., Okada, Y., Ishii, T., Horita, T., Saito, K., Okamoto, A., Nishimoto, N., Myouzen, K., et al. (2013) · Lara D. Veeken · doi:10.1093/rheumatology/kes427 · Cited by 76
Autoantibodies against EPCR are found in antiphospholipid syndrome and are a risk factor for fetal death
Hurtado, V. (2004) · Blood · doi:10.1182/blood-2004-03-0793 · Cited by 76
High-Sensitivity C-Reactive Protein as an Associate of Clinical Subsets and Organ Damage in Systemic Lupus Erythematosus
Lee, S., Singh, S., Link, K., & Petri, M. (2008) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2007.09.005 · Cited by 75
Thrombinography shows acquired resistance to activated protein C in patients with lupus anticoagulants
Regnault, V., Beguı́n, S., Wahl, D. G., et al. (2003) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1613433 · Cited by 75
Antiphospholipid antibodies and preeclampsia: a case-control study
Dreyfus, M. (2001) · Obstetrics and Gynecology · doi:10.1016/s0029-7844(00)01099-1 · Cited by 71
Pregnancy outcome is not affected by antiphospholipid antibody status in women referred for in vitro fertilization
Chilcott, I., Margara, R. A., Cohen, H., et al. (2000) · Fertility and Sterility · doi:10.1016/s0015-0282(99)00585-3 · Cited by 68
A “Percent Correction” Formula for Evaluation of Mixing Studies
Chang, S.-H., Tillema, V., & Scherr, D. (2002) · American Journal of Clinical Pathology · doi:10.1309/rrek-8l6m-d2kc-hwlh · Cited by 68
Activated protein C resistance determined with a thrombin generation‐based test is associated with thrombotic events in patients with lupus anticoagulants
Liestøl, S., Sandset, P. M., Mowinckel, M., et al. (2007) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2007.02734.x · Cited by 65
Surgery in patients with inherited bleeding disorders
Mensah, P., & Gooding, R. (2014) · Anaesthesia · doi:10.1111/anae.12899 · Cited by 63
1996 Diagnostic and Classification Criteria for the Antiphospholipid/Cofactors Syndrome: A ‘Mission Impossible’?
Pietté, J. C. (1996) · Lupus · doi:10.1177/096120339600500504 · Cited by 61
Diagnostic Uses of Snake Venom
Marsh, N. A. (2001) · Pathophysiology of Haemostasis and Thrombosis · doi:10.1159/000048065 · Cited by 62
Antinucleosome antibodies in primary antiphospholipid syndrome: A hint at systemic autoimmunity?
Andréoli, L., Pregnolato, F., Burlingame, R. W., Allegri, F., Rizzini, S., Fanelli, V., Radice, A., Corace, C., Sinico, R. A., Meroni, P. L., et al. (2008) · Journal of Autoimmunity · doi:10.1016/j.jaut.2007.11.004 · Cited by 60
APTT reagent with ellagic acid as activator shows adequate lupus anticoagulant sensitivity in comparison to silica‐based reagent
KUMANO, O., IEKO, M., NAITO, S., YOSHIDA, M., & TAKAHASHI, N. (2012) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2012.04906.x · Cited by 59
Drug-Induced Lupus Anticoagulants and Antiphospholipid Antibodies
Dlott, J. S., & Roubey, R. A. S. (2011) · Current Rheumatology Reports · doi:10.1007/s11926-011-0227-1 · Cited by 59
Patients with antiphosholipid syndrome and thrombotic recurrences: A real world observation (the Piedmont cohort study)
Bazzan, M., Vaccarino, A., Stella, S., Sciascia, S., Montaruli, B., Bertero, M. T., Carignola, R., Roccatello, D., & for the Piedmont APS Consortium (2016) · Lupus · doi:10.1177/0961203315617538 · Cited by 56
Prevalence and clinical significance of antiprothrombin antibodies in patients with systemic lupus erythematosus or with primary antiphospholipid syndrome.
Muñoz, F. J., Reverter, J. C., Font, J., Tàssies, D., Cervera, R., Espinosa, G., Carmona, F., Balasch, J., Ordinas, A., & Ingelmo, M. (2000) · PubMed · Cited by 56
Morbidity, Mortality, and Organ Damage in Patients with Antiphospholipid Syndrome
Grika, E., Ziakas, P. D., Zintzaras, E., Moutsopoulos, H. Μ., & Vlachoyiannopoulos, P. G. (2012) · The Journal of Rheumatology · doi:10.3899/jrheum.110800 · Cited by 54
Chronic or recurrent headache in patients with systemic lupus erythematosus: a case control study
Fernández‐Nebro, A., Palacios-Muñoz, R., Gordillo, J., et al. (1999) · Lupus · doi:10.1191/096120399678847443 · Cited by 53
Hypercoagulable States
Anderson, J. A. M., & Weitz, J. I. (2011) · Critical Care Clinics · doi:10.1016/j.ccc.2011.09.007 · Cited by 67
Decreased anticoagulant response to tissue factor pathway inhibitor type 1 in plasmas from patients with lupus anticoagulants
Liestøl, S., Sandset, P. M., Jacobsen, E. M., Mowinckel, M., & Wislöff, F. (2006) · British Journal of Haematology · doi:10.1111/j.1365-2141.2006.06385.x · Cited by 51
Clinical laboratory testing for the antiphospholipid syndrome
Pierangeli, S. S., & Harris, E. N. (2005) · Clinica Chimica Acta · doi:10.1016/j.cccn.2005.02.002 · Cited by 49
A comparison of two intensities of warfarin for the prevention of recurrent thrombosis in patients with the antiphospholipid antibody syndrome
Crowther, M. A., Ginsberg, J., & Julian, J. A. (2004) · ACC Current Journal Review · doi:10.1016/j.accreview.2003.10.079 · Cited by 50
The Lupus Ratio test--an interlaboratory study on the detection of Lupus anticoagulants by an APTT-based, integrated, and semi-quantitative test. Fifth International Survey of Lupus Anticoagulants--ISLA 5.
Jacobsen, E., Barna, L. K., Taylor, J., Triplett, D. A., & Wislöff, F. (2000) · PubMed · Cited by 49
Self-citation
Lupus anticoagulant acquired hypoprothrombinemia syndrome in childhood: two distinct patterns and review of the literature
Sarker, T. T., Roy, S., Hollon, W., et al. (2015) · Haemophilia · doi:10.1111/hae.12669 · Cited by 48
Increased risk of venous thromboembolism in patients with primary mediastinal large B-cell lymphoma
Leković, D., Miljić, P., & Mihaljević, B. (2010) · Thrombosis Research · doi:10.1016/j.thromres.2010.08.017 · Cited by 48
The obstetric antiphospholipid syndrome
Derksen, R. H. W. M., & de Groot, P. G. (2007) · Journal of Reproductive Immunology · doi:10.1016/j.jri.2006.12.003 · Cited by 50
Does the anti-β2-glycoprotein I antibody provide additional information in patients with thrombosis?
Lee, E. Y., Lee, C.-K., Lee, T. H., Chung, S. M., Kim, S. H., Cho, Y. S., Yoo, B., & Moon, H.-B. (2003) · Thrombosis Research · doi:10.1016/j.thromres.2003.08.023 · Cited by 47
Antiphospholipid antibodies — We are not quite there yet
Urbanus, R. T., & de Groot, P. G. (2011) · Blood Reviews · doi:10.1016/j.blre.2010.12.001 · Cited by 48
D-Dimer Level and the Risk for Thrombosis in Systemic Lupus Erythematosus
Wu, H. M., Birmingham, D. J., Rovin, B. H., Hackshaw, K. V., Haddad, N. F., Haden, D. W., Yu, C. Y., & Hebert, L. A. (2008) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.01480308 · Cited by 47
Correlation between the potency of a beta2-glycoprotein I-dependent lupus anticoagulant and the level of resistance to activated protein C
de Laat, B., Eckmann, C. M., van Schagen, M., Meijer, A. B., Mertens, K., & van Mourik, J. A. (2008) · Blood Coagulation & Fibrinolysis · doi:10.1097/mbc.0b013e32830f1b85 · Cited by 45
Hypercoagulable States
Anderson, J. A. M., & Weitz, J. I. (2010) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2010.07.004 · Cited by 46
Evolution of cardiac dysfunction in patients with antiphospholipid antibodies and/or antiphospholipid syndrome: A 10-year follow-up study
Kampolis, C. F., Tektonidou, M. G., Moyssakis, I. E., et al. (2013) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2013.07.016 · Cited by 45
Thyroid, hemostasis and thrombosis
Marongiu, F., Cauli, C., & Mariotti, S. (2004) · Journal of Endocrinological Investigation · doi:10.1007/bf03345311 · Cited by 45
Lupus Anticoagulants and Their Relationship with the Inhibitors against Coagulation Factor VIII: Considerations on the Differentiation between the 2 Circulating Anticoagulants
Tripodi, A., Mancuso, M. E., Chantarangkul, V., Clerici, M., Bader, R., Meroni, P. L., Santagostino, E., & Mannucci, P. M. (2005) · Clinical Chemistry · doi:10.1373/clinchem.2005.054312 · Cited by 44
An Unusual Cause of Neonatal Seizures in a Newborn Infant
de Klerk, O. L., de Vries, T. W., & Sinnige, L. G. F. (1997) · PEDIATRICS · doi:10.1542/peds.100.4.e8 · Cited by 42
Testing for lupus anticoagulants: all that a clinician should know
Tripodi, A. (2009) · Lupus · doi:10.1177/0961203308101436 · Cited by 41
Utility of Thrombin-Generation Assay in the Screening of Factor V G1691A (Leiden) and Prothrombin G20210A Mutations and Protein S Deficiency
Hézard, N., Bouaziz-Borgi, L., Rémy, M.-G., et al. (2006) · Clinical Chemistry · doi:10.1373/clinchem.2005.063339 · Cited by 40
Isolated elevation of IgA anti-β2glycoprotein I antibodies with manifestations of antiphospholipid syndrome: a case series of five patients
Kumar, S., Papalardo, E., Sunkureddi, P. R., Najam, S., González, E., & Pierangeli, S. (2009) · Lupus · doi:10.1177/0961203309103048 · Cited by 38
Development of Consensus Guidelines for Anticardiolipin and Lupus Anticoagulant Testing
Wong, R. C. W., Adelstein, S., Gillis, D., et al. (2005) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-2005-863804 · Cited by 36
Antibodies to prothrombin in antiphospholipid syndrome and inflammatory disorders
Guerin, J., Smith, O. P., White, B. C., Sweetman, G., Feighery, C., & Jackson, J. (1998) · British Journal of Haematology · doi:10.1046/j.1365-2141.1998.00876.x · Cited by 34
Laboratory tests for the antiphospholipid syndrome: current concepts
Passam, F. H., & Krilis, S. A. (2004) · Pathology · doi:10.1080/00313020410001671966 · Cited by 33
LUPUS ANTICOAGULANTS AND ANTIPHOSPHOLIPID ANTIBODIES
Thiagarajan, P., & Shapiro, S. S. (1998) · Hematology/Oncology Clinics of North America · doi:10.1016/s0889-8588(05)70048-4 · Cited by 34
Antiphospholipid antibodies and the risk of severe and non‐severe pre‐eclampsia: the NOHA case‐control study
Marchetti, T., de Moerloose, P., & Gris, J. (2016) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.13257 · Cited by 33
Pregnancy outcome in systemic lupus erythematosus: Asia’s largest single centre study
Aggarwal, N., Raveendran, A., Suri, V., et al. (2010) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-010-1618-7 · Cited by 33
Antibodies to Serine Proteases in the Antiphospholipid Syndrome
Chen, P. P., & Giles, I. (2010) · Current Rheumatology Reports · doi:10.1007/s11926-009-0072-7 · Cited by 33
Antiphospholipid antibiodies: a critical review of the literature
Lim, W., & Crowther, M. A. (2007) · Current Opinion in Hematology · doi:10.1097/moh.0b013e3282a4a65f · Cited by 32
Acquired thrombophilias and pregnancy
Khare, M., & Nelson‐Piercy, C. (2003) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/s1521-6934(03)00013-0 · Cited by 32
Are laboratories following published recommendations for lupus anticoagulant testing?
Moffat, K. A., Ledford-Kraemer, M., Plumhoff, E., McKay, H., Nichols, W., Meijer, P., & Hayward, C. P. M. (2008) · Thrombosis and Haemostasis · doi:10.1160/th08-06-0353 · Cited by 30
Livedo : de la physiopathologie au diagnostic
Duval, A., & Pouchot, J. (2008) · La Revue de Médecine Interne · doi:10.1016/j.revmed.2007.11.006 · Cited by 29
Recommendations for Evaluation of Coagulation Analyzers
Gardiner, C., Kitchen, S., Dauer, R., Kottke‐Marchant, K., & Adcock, D. (2006) · Laboratory Hematology · doi:10.1532/lh96.05031 · Cited by 29
The antiphospholipid syndrome
Pasquali, J., Poindron, V., Korganow, A., & Martin, T. (2008) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2008.08.008 · Cited by 28
The Effects of Indirect- and Direct-Acting Anticoagulants on Lupus Anticoagulant Assays
Seheult, J. N., Meyer, M. P., Bontempo, F. A., & Chibisov, I. (2017) · American Journal of Clinical Pathology · doi:10.1093/ajcp/aqx035 · Cited by 31
High risk of adverse pregnancy outcomes in women with a persistent lupus anticoagulant
Gebhart, J., Posch, F., Koder, S., Quehenberger, P., Perkmann, T., Kuessel, L., Ay, C., & Pabinger, I. (2019) · Blood Advances · doi:10.1182/bloodadvances.2018026948 · Cited by 29
Lupus Anticoagulant Assays: Questions Answered and to Be Answered
Teruya, J., West, A., & Suell, M. N. (2007) · Archives of Pathology & Laboratory Medicine · doi:10.5858/2007-131-885-laaqaa · Cited by 29
Immunoglobulin G from Patients with Antiphospholipid Syndrome Impairs the Fibrin Dissolution with Plasmin
Kolev, K., Gombás, J., Váradi, B., et al. (2002) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1613031 · Cited by 29
Clinical significance of acquired activated protein C resistance in patients with systemic lupus erythematosus
Muñoz, F. J., Reverter, J. C., Font, J., et al. (2002) · Lupus · doi:10.1191/0961203302lu256oa · Cited by 28
Lupus anticoagulant detection: out of control?
Moore, G. W., Brown, K. L., Bromidge, E. S., Drew, A. J., & Ledford‐Kraemer, M. R. (2013) · International Journal of Laboratory Hematology · doi:10.1111/ijlh.12006 · Cited by 27
Use of Dual TaqMan Probes to Increase the Sensitivity of 1-Step Quantitative Reverse Transcription-PCR: Application to the Detection of SARS Coronavirus
Yip, S. P., To, S. S. T., Leung, P. H. M., et al. (2005) · Clinical Chemistry · doi:10.1373/clinchem.2005.054106 · Cited by 27
Patterns of Recurrent Thrombosis in Primary Antiphospholipid Syndrome—Multicenter, Real-Life Long-Term Follow-Up
Niznik, S., Rapoport, M. J., Avnery, O. H., Lubetsky, A., Yahia, S. H., Ellis, M. H., & Agmon‐Levin, N. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.843718 · Cited by 27
Role of Thrombotic and Fibrinolytic Disorders in the Etiology of Perthes??? Disease
Koo, K., Song, H., Ha, Y., et al. (2002) · Clinical Orthopaedics and Related Research · doi:10.1097/00003086-200206000-00019 · Cited by 26
Tests for lupus anticoagulant revisited
Derksen, R. H. W. M., & de Groot, P. G. (2004) · Thrombosis Research · doi:10.1016/j.thromres.2004.06.009 · Cited by 27
Prolonged Activated Partial Thromboplastin Time
Ames, P. R. J., Graf, M. E., Archer, J., Scarpato, N., & Iannaccone, L. (2014) · Clinical and Applied Thrombosis/Hemostasis · doi:10.1177/1076029614541516 · Cited by 24
Influence of Antiphospholipid Antibodies on Pregnancy Outcome in Women Undergoing In Vitro Fertilization and Embryo Transfer
Lee, S., Park, E., Kim, S., et al. (2006) · American Journal of Reproductive Immunology · doi:10.1111/j.1600-0897.2006.00437.x · Cited by 24
Laboratory Evaluation of the Antiphospholipid Syndrome
Hoppensteadt, D. A., Fabbrini, N. J., Bick, R. L., et al. (2008) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2007.10.009 · Cited by 23

Authors: Brandt, J. T., Barna, L. K., & Triplett, D. A.
Affiliations: The Ohio State University (US)
Ball Memorial Hospital (US)
Venue: Thrombosis and Haemostasis
Publisher: Georg Thieme Verlag KG
Published: 1995
Volume: 74
Issue: 06
Pages: 1597-1603
ISSN: 0340-6245 (ISSN-L)
2567-689X
DOI: 10.1055/s-0038-1649988
OpenAlex: W2417920681
Cited by: 228
References: 27
Citations by year: 2026: 1 · 2024: 1 · 2023: 5 · 2022: 5 · 2021: 2 · 2019: 3 · 2018: 5 · 2017: 3 · 2016: 6 · 2015: 7 · 2014: 8 · 2013: 12 · 2012: 9
FWCI: 4.05
Type: journal article
Language: en
Open access: closed
Locations: Thrombosis and Haemostasis (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Rheumatology › Systemic Lupus Erythematosus Research
Health Sciences › Medicine › Hematology › Blood Coagulation and Thrombosis Mechanisms
Health Sciences › Medicine › Hematology › Hemophilia Treatment and Research
Keywords: lupus anticoagulant, mixing studies, activated partial thromboplastin time, factor deficiency, anticoagulants, factor VIII inhibitors, factor V inhibitor, oral anticoagulants
MeSH terms: Humans, Laboratories, Partial Thromboplastin Time, Predictive Value of Tests, Prothrombin Time, Reproducibility of Results, Lupus Coagulation Inhibitor

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Laboratory Identification of Lupus Anticoagulants: Results of the Second International Workshop for Identification of Lupus Anticoagulants: On behalf of the Subcommittee on Lupus Anticoagulants/Antiphospholipid Antibodies of the ISTH

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Citations

Cites

Cited by

Related

Metadata

Record

About these checks